EGFR gene mutations are some of the most commonly occurring mutations in non-small cell lung cancer. Investigators have developed a DNA instability model that estimates a risk score to assess the likelihood of an individual acquiring a cancer-linked mutation. The aim of this study is to collect blood from both those diagnosed with EGFR positive lung cancer and healthy individuals, evaluate their gene sequence surrounding the EGFR landscape and use the cancer positive and healthy sequences to validate the risk assessment model, which may one day be used to provide insight on susceptibility of getting EGFR positive lung cancer or potentially other cancer types.
Study Type
OBSERVATIONAL
Enrollment
20
A 10ml Blood sample will be taken and used to sequence the EGFR gene and surrounding DNA.
Subjects will have their DNA sequenced within and around the EGFR gene.
Our Lady of the Lake Regional Medical Center
Baton Rouge, Louisiana, United States
RECRUITINGDifferences in DNA sequence of EGFR gene
Subjects who have EGFR positive lung cancer will have their gene sequence compared to those that are EGFR negative and do not have lung cancer to look for differences in the sequence.
Time frame: From enrollment to end of data analysis at 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.